Evidence map›Paper›PMID 39500912›Full record

ArticleScientific reports2024

Detectability of cytokine and chemokine using ELISA, following sample-inactivation using Triton X-100 or heat.

Erica Hofer Labossiere, Sandra Gonzalez-Diaz, Stephanie Enns, Paul Lopez, Xuefen Yang, Biniam Kidane, Gloria Vazquez-Grande, Abu Bakar Siddik, Sam Kam-Pun Kung, Paul Sandstrom and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erica Hofer LabossiereJC WILT Infectious Disease Research Center, National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, MB, Canada.
Sandra Gonzalez-DiazJC WILT Infectious Disease Research Center, National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, MB, Canada.
Stephanie EnnsSection of Thoracic Surgery, Department of Surgery, Health Sciences Centre, University of Manitoba, Winnipeg, MB, Canada.
Paul LopezJC WILT Infectious Disease Research Center, National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, MB, Canada.
Xuefen YangJC WILT Infectious Disease Research Center, National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, MB, Canada.
Biniam KidaneSection of Thoracic Surgery, Department of Surgery, Health Sciences Centre, University of Manitoba, Winnipeg, MB, Canada.
Gloria Vazquez-GrandeSection of Critical Care, Department of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Abu Bakar SiddikJC WILT Infectious Disease Research Center, National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, MB, Canada.
Sam Kam-Pun KungDepartment of Immunology, University of Manitoba, Winnipeg, MB, Canada.
Paul SandstromJC WILT Infectious Disease Research Center, National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, MB, Canada.
Amir RavandiCardiovascular Lipidomics, Institute of Cardiovascular Sciences, St. Boniface Hospital, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
T Blake BallJC WILT Infectious Disease Research Center, National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, MB, Canada.
Ruey-Chyi SuJC WILT Infectious Disease Research Center, National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, MB, Canada. ruey.c.su@phac-aspc.gc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical samples are routinely inactivated before molecular assays to prevent pathogen transmission. Antibody-based assays are sensitive to changes in analyte conformation, but the impact of inactivation on the analyte detectability has been overlooked. This study assessed the effects of commonly used inactivation-methods, Triton X-100 (0.5%) and heat (60 °C, 1 h), on cytokine/chemokine detection in plasma, lung aspirates, and nasopharyngeal samples. Heat significantly reduced analyte detectability in plasma (IL-12p40, IL-15, IL-16, VEGF, IL-7, TNF-β) by 33-99% (p ≤ 0.02), while Triton X-100 minimally affected analytes in plasma and nasopharyngeal samples (11-37%, p ≤ 0.04) and had no significant impact on lung aspirates. Structural analysis revealed that cytokines affected by heat had more hydrophobic residues and higher instability-indices. As the protein-detectability was affected differently in different sample types, the sample environment could also influence protein stability. This underscores the importance of selecting the most suitable inactivation methods for clinical samples to ensure accurate cytokine/chemokine analysis in both clinical and research settings.

Indexed as

CytokinesEnzyme-Linked Immunosorbent AssayHot TemperatureOctoxynolChemokinesHumansLungNasopharynxSpecimen HandlingChemokinesCytokinesOctoxynolCytokine/chemokineELISAHeat-inactivationLung aspirateNasopharyngeal swabTriton X-100

Identifiers

PMID39500912
PMCPMC11538312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.